おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Mozart Therapeutics
company
About
The company intended to focus on developing novel immune engagers.
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $55M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2020
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$55M
Mozart Therapeutics has raised a total of
$55M
in funding over 2 rounds. Their latest funding was raised on
Oct 26, 2021 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Oct 26, 2021 | Series A | $55M | 1 |
ARCH Venture Partners
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
Mozart Therapeutics is funded by 1 investors.
ARCH Venture Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
ARCH Venture Partners
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
